Occidental Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$354K Buy
3,211
+16
+0.5% +$1.54K 0.03% 257
2026
Q2
$250K Sell
3,195
-464
-13% -$31.6K 0.02% 270
2026
Q1
$236K Sell
3,659
-3,136
-46% -$221K 0.03% 246
2025
Q4
$457K Sell
6,795
-944
-12% -$63.5K 0.05% 166
2025
Q3
$568K Sell
7,739
-3
-0% -$199 0.07% 146
2025
Q2
$403K Buy
7,742
+1,656
+27% +$94.2K 0.06% 167
2025
Q1
$388K Buy
+6,086
New +$354K 0.06% 159

Other funds holding HALO

Occidental Asset Management's HALO Position: Q3 2026 in Review

Occidental Asset Management increased its Halozyme (HALO) stake by 0.5% in Q3 2026, buying an estimated $1.54K and bringing the position to 3,211 shares worth $354K. The position accounts for 0.03% of the portfolio, ranked #257.

Occidental Asset Management first reported a position in HALO in Q1 2025 and has held it in 7 quarters since. The position peaked at $568K in Q3 2025. 773 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Occidental Asset Management held 3,211 shares of Halozyme worth $354K as of Q3 2026.
  • Occidental Asset Management bought 16 Halozyme shares in Q3 2026, an estimated $1.54K.
  • Halozyme made up 0.03% of Occidental Asset Management's portfolio in Q3 2026, its #257 holding.
  • Occidental Asset Management first reported a position in Halozyme in Q1 2025 and has held it in 7 quarters since.
  • Occidental Asset Management's Halozyme position peaked at $568K in Q3 2025.
  • 773 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Occidental Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.